PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-36069 |   Service

Historical data: 2017 - 2023

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2025 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Prostate Specific Antigen (Psa) Testing Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET

7.1 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 Abbott Laboratories, Inc

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Bayer AG

16.3 Beckman Coulter, Inc

16.4 GE Helathcare

16.5 GlaxoSmithKline, plc

16.6 Novartis Pharma AG

16.7 UroLogix, Inc

16.8 Bristol - Myers Squibb Company

16.9 AstraZeneca plc

16.10 Johnson & Johnson Diagnostics

16.11 BioChem Pharma

16.12 Pharmacia Delfia

16.13 Roche Diagnostics

16.14 Olympus

16.15 Tosho

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Free Prostate Specific Antigen Test
Complex Prostate Specific Antigen Test
Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test

By Application
Application â… 
Application â…¡
Application â…¢
Application â…£
Application â…¤

Companies

Abbott Laboratories, Inc
Bayer AG
Beckman Coulter, Inc
GE Helathcare
GlaxoSmithKline, plc
Novartis Pharma AG
UroLogix, Inc
Bristol - Myers Squibb Company
AstraZeneca plc
Johnson & Johnson Diagnostics
BioChem Pharma
Pharmacia Delfia
Roche Diagnostics
Olympus
Tosho

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.